주요 내용으로 건너 뛰기

Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future

The article “Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future” by Karen Rowland Yeo, Eva Gil Berglund, and Yuan Chen, published in Clinical Pharmacology & Therapeutics, reviews the current landscape of physiologically-based pharmacokinetic (PBPK) modeling in drug development. It highlights PBPK’s expanding role in dose optimization, regulatory submissions, and its application to diverse and underrepresented populations. The article also discusses challenges, such as model validation and future directions, including the integration of PBPK with machine learning and Quantitative Systems Pharmacology (QSP) to enhance personalized medicine.

Reference: Clinical Pharmacology & Therapeutics, State of the Art Review, Open Access.

Author(s): Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen

Year: 4월 30, 2024

Powered by Translations.com GlobalLink Web Software